Bioactive Materials (Apr 2024)

Covalently grafted human serum albumin coating mitigates the foreign body response against silicone implants in mice

  • Xianchi Zhou,
  • Hongye Hao,
  • Yifeng Chen,
  • Wenzhong Cao,
  • Zihao Zhu,
  • Yanwen Ni,
  • Zuolong Liu,
  • Fan Jia,
  • Youxiang Wang,
  • Jian Ji,
  • Peng Zhang

Journal volume & issue
Vol. 34
pp. 482 – 493

Abstract

Read online

Implantable biomaterials and biosensors are integral components of modern medical systems but often encounter hindrances due to the foreign body response (FBR). Herein, we report an albumin coating strategy aimed at addressing this challenge. Using a facile and scalable silane coupling strategy, human serum albumin (HSA) is covalently grafted to the surface of polydimethylsiloxane (PDMS) implants. This covalently grafted albumin coating remains stable and resistant to displacement by other proteins. Notably, the PDMS with covalently grafted HSA strongly resists the fibrotic capsule formation following a 180-day subcutaneous implantation in C57BL/6 mice. Furthermore, the albumin coating led to reduced recruitment of macrophages and triggered a mild immune activation pattern. Exploration of albumin coatings sourced from various mammalian species has shown that only HSA exhibited a promising anti-FBR effect. The albumin coating method reported here holds the potential to improve and extend the function of silicone-based implants by mitigating the host responses to subcutaneously implanted biomaterials.

Keywords